Reaction
Haemobilia reporting signals
As of the last recalculation, Haemobilia appears in 407 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is SORAFENIB (PRR 35.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sorafenib | 14 | 35.7 | 35.7 |
| Lenvatinib | 20 | 32.7 | 32.8 |
| Emicizumab | 7 | 29.5 | 29.5 |
| Atezolizumab | 19 | 26.2 | 26.2 |
| Gemcitabine Hydrochloride | 19 | 19.2 | 19.2 |
| Durvalumab | 5 | 12.7 | 12.7 |